Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

WHY I STILL DIG THIS!

$Better Therapeutics(BTTX.US)$ As you read keep in mind that R/S is on the table for compliance by 12/13/23? Here is a caveat though. They can ask for another 180 day extension! Now thats out there, ill post my original intent of why i dig this! Read for your investment decision! Hehehe ((((((    Expected Upcoming Milestones
● Obtain Commercial Payer Coverage for AspyreRx: Better Therapeutics is currently engaged in advanced discussions with multiple commercial payers and expects to announce an agreement by the end of this year. The Company has submitted its Federal Supply Schedule (FSS) application and is awaiting to be assigned a contract negotiator. Once on the FSS, AspyreRx would be available to be prescribed to Veterans that receive care via the VA network.
● Request Breakthrough Device Designation: Following the successful completion of the LivVita Liver Study and publication of the results in the peer-reviewed journal Gastro Hep Advances, Better Therapeutics intends to submit a request to the FDA for Breakthrough Device Designation for its investigational PDT in MASLD and MASH by the end of 2023. Currently, there is no FDA approved treatment for MASLD and MASH, which affect approximately one in four Americans. Behavioral change is foundational to addressing the root causes of the diseases and the Company believes that a prescription treatment option could be of significant benefit to millions of patients.
● Announce a Business Development Partnership: To support the commercialization of AspyreRx, Better Therapeutics expects to announce a business development partnership by the end of this year. ● Further Strengthen Financial Position: Better Therapeutics expects to further strengthen its financial position in the fourth quarter to extend its financial runway.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
4
+0
40
Translate
Report
18K Views
Comment
Sign in to post a comment

View more comments...

1796Followers
29Following
21KVisitors
Follow